Clinical Trial Update: Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer [Phase 1]

View source ↗

Summary

This document describes a Phase 1 clinical trial evaluating an antiangiogenic peptide vaccine in combination with gemcitabine for pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• antiangiogenic peptide vaccine therapy

Snippet

Sponsor: Fukushima Medical University | Conditions: Pancreatic Cancer | Phase 1 | Status: UNKNOWN